Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Gene expression in intrahepatic tumors through DNA recombination by a replication-activated adenovirus vector

Abstract

One strategy for improving selectivity of gene therapy is the use of a replication-activated adenovirus vector that mediates transgene expression specifically in tumor cells through homologous recombination of viral genomes. In this study, we compared replication-activated adenovirus containing inverted repeats (Ad.IR-BG) with IR-deficient virus (Ad.BG) for selective gene expression in hepatocellular carcinoma and colon carcinoma metastases in the liver. We found that Ad.IR-BG conferred specific gene expression in both carcinoma cells, with minimal expression in hepatocytes and colon epithelial cells. This occurred through viral DNA recombination in Ad.IR-BG-infected tumor cells but not in normal cells. Hydroxyurea, which blocks DNA replication, inhibited DNA recombination and β-gal expression in Ad.IR-BG-infected but not Ad.BG-infected tumor cells. Finally, systemic injection of Ad.IR-BG into tumor xenografts in nude mice significantly improved selectivity of gene expression in tumors with minimal expression in normal tissues. Viral DNA recombination, which was absent in normal liver, was detected in Ad.IR-BG-infected tumors but not in Ad.BG-infected tissue. These findings demonstrated that replication-activated adenovirus can mediate tumor-specific gene expression through viral DNA recombination, which is otherwise deficient in normal cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 2
Figure 1
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. O'Connell MJ, Nagorney DM, Bernath AM, et al. Sequential intrahepatic fluorodeoxyuridine and systemic fluorouracil plus leucovorin for the treatment of metastatic colorectal cancer confined to the liver. J Clin Oncol. 1998;16:2528–2533.

    Article  CAS  PubMed  Google Scholar 

  2. Harmantas A, Rotstein LE, Langer B . Regional versus systemic chemotherapy in the treatment of colorectal carcinoma metastatic to the liver: is there a survival difference? Meta-analysis of the published literature. Cancer (Phila). 1996;78:1639.

    Article  CAS  Google Scholar 

  3. Tang ZY . Hepatocellular carcinoma — cause, treatment and metastasis. World J Gastroenterol. 2001;7:445–454.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Grill J, Van Beusechem VW, Curiel DT, Gerritsen WR . Combined targeting of adenoviruses to integrins and epidermal growth factor receptors increases gene transfer into primary glioma cells and spheroids. Clin Cancer Res. 2001;7:641–650.

    CAS  PubMed  Google Scholar 

  5. Zhang M, Li SP, Nyati MK, et al. Regional delivery and selective expression of a high-activity yeast cytosine deaminase in an intrahepatic colon cancer model. Cancer Res. 2003;63:658–663.

    CAS  PubMed  Google Scholar 

  6. Nayti MK, Sreekumar SP, Li SP, et al. High and selective expression of yeast cytosine deaminase under a carcinoembryonic antigen promoter-enhancer. Cancer Res. 2002;62:2337–2342.

    Google Scholar 

  7. Bischoff JR, Kirn DH, Williams A, et al. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science. 1996;274:373–376.

    Article  CAS  PubMed  Google Scholar 

  8. Johnson L, Shen A, Boyle L, et al. Selective replicating adenoviruses targeting deregulated E2F activity are potent, systemic antitumor agents. Cancer Cell. 2002;1:325–337.

    Article  CAS  PubMed  Google Scholar 

  9. Khuri FR, Nemunaitis J, Ganly I, et al. A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer. Nat Med. 2000;6:879–885.

    Article  CAS  PubMed  Google Scholar 

  10. Nemunaitis J, Cunningham C, Buchanan A, et al. Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity. Gene Therapy. 2001;8:746–759.

    Article  CAS  PubMed  Google Scholar 

  11. Steinwaerder DS, Carlson CA, Lieber A . DNA replication of first-generation adenovirus vectors in tumor cells. Hum Gene Ther. 2000;11:1933–1948.

    Article  CAS  PubMed  Google Scholar 

  12. Steinwaerder DS, Carlson CA, Lieber A . Generation of adenovirus vectors devoid of all viral genes by recombination between inverted repeats. J Virol. 1999;73:9303–9313.

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Steinwaerder DS, Carlson CA, Otto DL, et al. Tumor-specific gene expression in hepatic metastases by a replication-activated adenovirus vector. Nat Med. 2001;7:240–243.

    Article  CAS  PubMed  Google Scholar 

  14. Bernt KM, Steinwaerder DS, Ni SH, et al. Enzyme-activated prodrug therapy enhances tumor-specific replication of adenovirus vectors. Cancer Res. 2002;62:6089–6098.

    CAS  PubMed  Google Scholar 

  15. Rothmann T, Hengstermann A, Whitaker NJ, et al. Replication of ONYX-015, a potential anticancer adenovirus, is independent of p53 status in tumor cells. J Virol. 1998;72:9470–9478.

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Hallenbeck PL, Chang YN, Hay C, et al. A novel tumor-specific replication-restricted adenoviral vector for gene therapy for hepatocellular carcinoma. Hum Gene Ther. 1999;10:1721–1733.

    Article  CAS  PubMed  Google Scholar 

  17. Li YH, Yu DC, Chen Y, et al. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin. Cancer Res. 2001;61:6428–6436.

    CAS  PubMed  Google Scholar 

  18. Matsubara S, Wada Y, Gardner TA, et al. A conditional replication-competent adenoviral vector, Ad-OC-E1a, to cotarget prostate cancer and bone stroma in an experimental model of androgen-independent prostate cancer bone metastasis. Cancer Res. 2001;61:6012–6019.

    CAS  PubMed  Google Scholar 

  19. Nelson JE, Kay MA . Persistence of recombinant adenovirus in vivo is not dependent on vector DNA replication. J Virol. 1997;71:8902–8907.

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Rae RS, Mehta PP, Chang CC, et al. Neoplastic phenotype of gap-junctional intercellular communication-deficient WB rat liver epithelial cells and its reversal by forced expression of connexin 32. Mol Carcinogen. 1998;22:120–127.

    Article  CAS  Google Scholar 

  21. Freytag SO, Khil M, Stricker H, et al. Phase I study of replication-competent adenovirus-mediated double suicide gene therapy for the treatment of locally recurrent prostate cancer. Cancer Res. 2002;62:4968–4976.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Mary Davis (Department of Radiation Oncology, University of Michigan) for reviewing this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ming Zhang.

Additional information

Supported by NIH grants CA80145, CA84117, Cancer Center Core Grant CA46592.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Huang, X., Lieber, A., Tang, Z. et al. Gene expression in intrahepatic tumors through DNA recombination by a replication-activated adenovirus vector. Cancer Gene Ther 11, 450–456 (2004). https://doi.org/10.1038/sj.cgt.7700719

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.cgt.7700719

Keywords

This article is cited by

Search

Quick links